JY
PVLA

Jeff Yass’s Palvella Therapeutics PVLA Stock Holding History

Jeff Yass’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Buy
76,600
+44,100
+136% +$5.35M ﹤0.01% 3141
2026
Q1 		$4.05M Buy
+32,500
New +$3.39M ﹤0.01% 4632
2025
Q4 		– Sell
-5,100
Closed -$320K – 13958
2025
Q3 		$320K Buy
+5,100
New +$227K ﹤0.01% 9965
2022
Q3 		– Sell
-130
Closed -$19K – 14291
2022
Q2 		$19K Buy
+130
New +$23.7K ﹤0.01% 12380
2021
Q4 		– Sell
-2,596
Closed -$1.07M – 14061
2021
Q3 		$1.07M Buy
2,596
+811
+45% +$282K ﹤0.01% 7373
2021
Q2 		$547K Buy
+1,785
New +$391K ﹤0.01% 9366
2021
Q1 		– Sell
-279
Closed -$56K – 12949
2020
Q4 		$56K Buy
279
+11
+4% +$2.29K ﹤0.01% 10719
2020
Q3 		$44K Buy
+268
New +$61K ﹤0.01% 10237
2019
Q4 		– Sell
-914
Closed -$249K – 10823
2019
Q3 		$249K Buy
+914
New +$354K ﹤0.01% 8686
2019
Q1 		– Sell
-393
Closed -$84K – 10005
2018
Q4 		$84K Sell
393
-418
-52% -$130K ﹤0.01% 8294
2018
Q3 		$363K Sell
811
-387
-32% -$168K ﹤0.01% 7098
2018
Q2 		$486K Sell
1,198
-565
-32% -$269K ﹤0.01% 6854
2018
Q1 		$962K Buy
1,763
+1,504
+581% +$931K ﹤0.01% 5334
2017
Q4 		$156K Buy
259
+53
+26% +$24.6K ﹤0.01% 8461
2017
Q3 		$95K Buy
+206
New +$88K ﹤0.01% 8381

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Jeff Yass's PVLA Position: Q2 2026 in Review

Jeff Yass reduced its Palvella Therapeutics (PVLA) stake by 7.5% in Q2 2026, selling an estimated $171K and leaving 17,397 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #5873.

Jeff Yass first reported a position in PVLA in Q2 2015 and has held it in 25 quarters since. The position peaked at $3.2M in Q1 2025. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Jeff Yass held 17,397 shares of Palvella Therapeutics worth $2.66M as of Q2 2026.
  • Jeff Yass sold 1,411 Palvella Therapeutics shares in Q2 2026, an estimated $171K.
  • Palvella Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5873 holding.
  • Jeff Yass first reported a position in Palvella Therapeutics in Q2 2015 and has held it in 25 quarters since.
  • Jeff Yass's Palvella Therapeutics position peaked at $3.2M in Q1 2025.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.